Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs – Reuters
Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs Reuters
IJMS, Vol. 27, Pages 759: A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms
IJMS, Vol. 27, Pages 759: A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms International Journal of Molecular Sciences doi: 10.3390/ijms27020759 Authors: Charalampos Voros Fotios Chatzinikolaou Ioannis Papapanagiotou Spyridon Polykalas Despoina Mavrogianni Aristotelis-Marios Koulakmanidis Diamantis Athanasiou Vasiliki Kanaka Kyriakos Bananis Antonia Athanasiou Aikaterini Athanasiou Georgios Papadimas […]
The hidden health risk of taking weight loss drugs – and what to do about it
A recent review found that many people taking GLP-1 drugs receive little or no meaningful nutrition advice
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH Phase 3 Registrational Program in Obesity SAN DIEGO, Jan. 12, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Viking)…
What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting “GLP-3s,” claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) medications work by mimicking a naturally occurring hormone in the body that helps regulate blood sugar and appetite. The informal term “GLP-3” refers to a […]
Amazon Pharmacy offers Wegovy weight-loss pill
Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill, a move likely to intensify the drug’s impact on waistlines, grocery bills, and the food industry as a whole. The Danish drugmaker hopes the new oral version could revive its fortunes, with its share price and profits flagging in the last year. Novo might be struggling, […]
Suvannavejh: The obesity space has become a major focus for investors
Graig Suvannavejh, Biotech and Biopharma Analyst at Mizuho Securities, says Oral GLP-1 obesity drugs and looming patent cliffs will drive big pharma into biotech M&A, especially in oncology, immunology and neurology.
Consumer Trends 2026: 10 Key Facts Every CMO Should Consider
FOTOARTE: MERCA2.0 What are the consumer trends for 2026? The consumer is no longer the same as just two years ago. More demanding, more hybrid, more influenced by artificial intelligence (AI), and deeply affected by economic uncertainty, their habits are reshaping marketing, product innovation, and retail decisions. These are the 10 key trends from Statista’s […]
How to Suppress Your Appetite and Naturally Boost GLP-1
Can eating more fiber result in eating fewer calories by suppressing our appetite? For more on fiber, check out: • Is Fiber an Effective Anti-Inflammatory? (https://nutritionfacts.org/video/is-fiber-an-effective-anti-inflammatory/) • The Five to One Fiber Rule (https://nutritionfacts.org/video/the-five-to-one-fiber-rule/) • Juicing Removes More Than Just Fiber (https://nutritionfacts.org/video/juicing-removes-more-than-just-fiber/) For more on GLP-1, see my book OZEMPIC: Risks, Benefits, and Natural Alternatives […]
Causes And Implications Of Discontinuing GLP-1 Weight Loss Drugs
Discontinuing obesity medicines means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.